id: NEW:aud_treatment_evidence_gap_primary_care_to_NEW:aud_pharmacotherapy_prescription_rate
name: AUD Treatment Evidence Gap in Primary Care â†’ AUD Pharmacotherapy Prescription Rate
from_node:
  node_id: NEW:aud_treatment_evidence_gap_primary_care
  node_name: AUD Treatment Evidence Gap in Primary Care
to_node:
  node_id: NEW:aud_pharmacotherapy_prescription_rate
  node_name: AUD Pharmacotherapy Prescription Rate
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: There is a lack of data and studies on the efficacy of anti-craving treatment specifically
  in primary care settings'
- 'Step 2: Without primary care-specific evidence, providers lack confidence in treatment effectiveness
  in their context'
- 'Step 3: Uncertainty about efficacy in primary care settings reduces willingness to prescribe'
- 'Step 4: Lower prescription rates for AUD pharmacotherapy in primary care persist'
evidence:
  quality_rating: B
  n_studies: 10
  primary_citation: Guillou L Morgane et al. 2021. "The Place of Pharmacotherapy in Alcohol Use Disorder
    Management in Family Practice - A Systematic Review.." https://doi.org/10.2174/1381612826666201015154051
  supporting_citations:
  - 296 studies initially screened with only 10 meeting inclusion criteria
  - Additional citations require full-text access
  doi: 10.2174/1381612826666201015154051
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The review explicitly notes a lack of data and studies on the efficacy of anti-craving treatment
  in primary care settings, despite primary care being where most AUD patients present. This research
  gap perpetuates treatment uncertainty and underuse.
moderators:
- name: research_funding_priorities
  direction: strengthens
  strength: weak
  description: Research funding priorities that favor specialty over primary care settings perpetuate
    the evidence gap
structural_competency:
  equity_implications: This mechanism highlights how research infrastructure and funding priorities create
    structural barriers to equitable care. When evidence is generated primarily in specialty settings
    inaccessible to many patients, it cannot inform practice in the settings where care is most needed,
    perpetuating treatment gaps that disproportionately affect underserved populations.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.265413'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
